Global Angioplasty Balloons Market: Snapshot 

The key driver improving the demand for angioplasty balloons over the coming years is the growing number of patients suffering from coronary artery diseases. In the U.S. alone, 610,000 people have died from heart complications in the recent past, and close to 8 mn people have been diagnosed with peripheral artery disease in 2011. These numbers are growing, a trend very visible across the globe. The growing geriatric population, the increasing number of diabetics and the obese, and the high rate of negative lifestyle choices and stress have all culminated in increasing the number of people suffering from heart diseases and coronary artery disease. This collectively forms the primary factor responsible for the growing demand for angioplasty balloons. 

The market is additionally experiencing a regular introduction of innovative products and pipeline releases, further promoting the use of angioplasty balloons. All these factors have resulted in a predicted CAGR of 3.5% for angioplasty balloon revenue generation from 2015 to 2023. By the end of 2016, this market revenue is expected to reach US$2.06 bn and US$2.54 bn by 2023. 

North America Dominates Angioplasty Balloon Usage Rate

By 2023, the North America angioplasty balloons market is expected to account for 38.97% of the global market’s value. This region is experiencing an especially high increase in the number of patients suffering from cardiovascular diseases. Additionally, the number of healthcare facilities in the region is increasing and so is the rate of awareness regarding the number of treatments available for heart diseases and peripheral artery disease. The region is also a hub of technological advancements and development of new products, further boosting the market. 

Europe is second in the global angioplasty balloons market in terms of revenue generated, owing to a very high percentage of geriatric population and an increase in the number of angioplasty surgeries being performed in countries such as France, Sweden, Austria, and Belgium. Additionally, the increasing number of non-invasive cardiovascular procedures is creating a higher preference for the use of angioplasty balloons. 

Normal Angioplasty Balloons Expected to Remain Dominant in Use and Demand

By the end of 2023, the revenue generated by normal angioplasty balloons is expected to reach US$1.57 bn. It was the first type of angioplasty balloon to ever be approved for use and has been a mainstay in this field for a long time, allowing it to gain major ground in popularity and development efforts. Its first-mover advantage is expected to continue working in its favor till 2023. 

However, the demand for drug coated angioplasty balloons is expected to increase significantly over the coming years, owing to high development efforts conducted in the field. Drug coated angioplasty balloons offer a faster and shorter surgical procedure, along with efficient local drug delivery that can help preserve the anatomy of the patient. The use of drug coated angioplasty balloons also helps avoid the need for extending anti-platelet therapy, which was the case with normal angioplasty balloons. 

The top manufacturers of angioplasty balloons in the world include Abbott Laboratories, Inc., BIOTRONIK SE & CO. KG, Cook Medical, Medtronic Plc., Cordis Corporation, ENDOCOR GmbH, C. R. Bard, Inc., Boston Scientific Corporation, Opto Circuits (India) Limited, NATEC Medical, and Spectranetics Corporation.


Balloon angioplasty is a minimally invasive procedure that widens the obstructed blood vessels. This report is on global angioplasty balloons studies the current and future prospects of the market. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments included in the study. This section also provides the overall information and data analysis of the global angioplasty balloons market with respect to the leading market segments based on type of balloons, material used, and geography.


The market overview section of the report includes qualitative analysis of the overall angioplasty balloons market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces analysis and market attractiveness analysis. In addition, various analyses such as market attractiveness analysis, by geography and competitive landscape, by key players has also been provided. The market attractiveness analysis is provided in order to explain the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.


The global angioplasty balloon market has been segmented on the basis of product type, material, and geography. Based on product type, the angioplasty balloons market has been categorized into four major segments: normal balloon, drug eluting balloon, cutting balloon, and scoring balloon. On the basis of material, the global angioplasty balloon market has been majorly segmented into two types: non-compliant balloon, and semi-compliant balloon. Market revenue in terms of USD million for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all the segments, considering 2014 as the base year.


Geographically, the angioplasty balloon market has been categorized into six regions: North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia-Pacific comprises China, India, and Rest of Asia-Pacific. Latin America comprises Brazil, Mexico, and Rest of Latin America. Middle East and North Africa comprises Saudi Arabia, the United Arab Emirates and Rest of MENA. The recommendations section included in the report would assist existing players to expanding their market share and new companies in establishing their presence in the angioplasty balloon market. The report also profiles major players in the angioplasty balloons market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Laboratories, Inc., BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, C. R. Bard, Inc., ENDOCOR GmbH, Medtronic plc, Opto Circuits (India) Limited, NATEC Medical, Spectranetics Corporation.


The global Angioplasty Balloons market is segmented as follows:


Global Angioplasty Balloons Market, by Balloon Type

  • Normal Balloon
  • Drug coated Balloon
  • Cutting Balloon
  • Scoring Balloon

Global Angioplasty Balloons Market, by Material

  • Non-compliant Balloon 
  • Semi-compliant Balloon

Global Angioplasty Balloons Market, by Geography

  • North America

    • U.S.
    • Canada
  • Europe

    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific

    • China
    • India
    • Rest of Asia Pacific
  • Latin America (LATAM)

    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East North Africa (MENA)

    • Saudi Arabia
    • United Arab Emirates
    • Rest of MENA
  • Rest of the World (RoW)